Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities (2010 - 2025)

Ironwood Pharmaceuticals (IRWD) has 16 years of Cash from Investing Activities data on file, last reported at $1000.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Investing Activities changed N/A year-over-year to $1000.0; the trailing twelve-month figure through Dec 2025 stood at -$34000.0 (up 76.06% YoY), and the FY2025 full-year result was -$34000.0, up 76.06% from the prior year.
• Cash from Investing Activities rose to $1000.0 in Q4 2025, from -$2000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $27000.0 in Q4 2022 to a low of -$999.5 million in Q2 2023.
• A 5-year average of -$64.2 million and a median of -$44500.0 in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities jumped 121.09% in 2022 and plunged 1135686.36% in 2023, its largest moves.
• Tracing IRWD's Cash from Investing Activities over 5 years: stood at -$128000.0 in 2021, then jumped by 121.09% to $27000.0 in 2022, then slumped by 15611.11% to -$4.2 million in 2023, then surged by 99.62% to -$16000.0 in 2024, then surged by 106.25% to $1000.0 in 2025.
• Business Quant data shows IRWD's Cash from Investing Activities at $1000.0 in Q4 2025, -$2000.0 in Q3 2025, and -$2000.0 in Q2 2025.